ABT240809P103000
- 0.09
- 0.000.00%
Abbott Laboratories Newsroom
Abbott Labs Leaders to Face Some Investor Claims Over Infant Formula
Government Of Quebec Has Expanded Public Reimbursement Of Abbott's FreeStyle Libre 2 Flash Glucose Monitoring System To More Adults With Diabetes
ECI Announces Brijesh Patel as New CEO
Wells Fargo Keeps Their Buy Rating on Abbott Laboratories (ABT)
Express News | Live On CNBC, Karen Firestone Announces Bought Abbott Labs, Costar Group
Express News | Medical Device Makers Abbott Laboratories and Medtronic Each Rise Over 1.7% on Glucose Monitoring Partnership
Medtronic Wins FDA Approval for Simplera CGM
Is Trending Stock Abbott Laboratories (ABT) a Buy Now?
Express News | Abbott Announces Global Partnership With Medtronic To Integrate FreeStyle Libre CGM Sensors With Medtronic's Insulin Delivery Systems; Expands Connectivity With Four Major Automated Insulin Delivery Companies
Express News | Abbott - Financial Terms of Partnership and Timing for Commercial Availability Were Not Disclosed
IDEXX (IDXX) Q2 Earnings Miss Estimates, 2024 View Down
Abbott Enters Global Partnership to Connect Its World-Leading Continuous Glucose Monitoring System With Medtronic's Insulin Delivery Devices
Are Street Analysts Bullish on Abbott Laboratories (ABT) Right Now?
Cadrenal Therapeutics in Talks With Abbott to Study Tecarfarin in Patients With LVAD
Top Overweight and Low-volatility Picks in Staples, Healthcare, and Utilities - WF
Express News | Cadrenal Therapeutics and Abbott Initiate Collaborative Effort to Advance Novel Anticoagulant Tecarfarin for Patients With Lvads
Abbott Laboratories Second Quarter 2024 Earnings: EPS Misses Expectations
DexCom, Abbott to Benefit From Multi-billion-dollar OTC Continuous Glucose Market
Abbott Laboratories | 10-Q: Q2 2024 Earnings Report
Jim Cramer Says This Home Improvement Chain Is A Buy Ahead Of Fed Rate Cut Cycle: 'I Would Pick Some Up Tomorrow'